PCC Rokita SA

WSE:PCR Stock Report

Market Cap: zł1.5b

PCC Rokita Management

Management criteria checks 3/4

PCC Rokita's CEO is Wieslaw Klimkowski, appointed in Jan 2005, has a tenure of 20.17 years. total yearly compensation is PLN20.28M, comprised of 14.1% salary and 85.9% bonuses, including company stock and options. directly owns 0.5% of the company’s shares, worth PLN7.52M. The average tenure of the management team and the board of directors is 15.2 years and 9.2 years respectively.

Key information

Wieslaw Klimkowski

Chief executive officer

zł20.3m

Total compensation

CEO salary percentage14.1%
CEO tenure20.2yrs
CEO ownership0.5%
Management average tenure15.2yrs
Board average tenure9.2yrs

Recent management updates

Recent updates

Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

May 30
Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Aug 24
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 29
PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Apr 16
PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Why We Like The Returns At PCC Rokita (WSE:PCR)

Mar 19
Why We Like The Returns At PCC Rokita (WSE:PCR)

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

Jan 25
What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Sep 01
We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Jun 14
Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

May 18
Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Apr 13
Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

Mar 23
Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Mar 09
PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Feb 19
Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Feb 04
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Jan 15
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Dec 30
Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

Dec 17
Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 03
PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Nov 20
Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

CEO Compensation Analysis

How has Wieslaw Klimkowski's remuneration changed compared to PCC Rokita's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

zł121m

Jun 30 2024n/an/a

zł158m

Mar 31 2024n/an/a

zł144m

Dec 31 2023zł20mzł3m

zł268m

Sep 30 2023n/an/a

zł473m

Jun 30 2023n/an/a

zł589m

Mar 31 2023n/an/a

zł692m

Dec 31 2022zł43mzł2m

zł675m

Sep 30 2022n/an/a

zł569m

Jun 30 2022n/an/a

zł499m

Mar 31 2022n/an/a

zł472m

Dec 31 2021zł10mzł826k

zł417m

Sep 30 2021n/an/a

zł294m

Jun 30 2021n/an/a

zł247m

Mar 31 2021n/an/a

zł171m

Dec 31 2020zł5mzł573k

zł117m

Sep 30 2020n/an/a

zł73m

Jun 30 2020n/an/a

zł82m

Mar 31 2020n/an/a

zł72m

Dec 31 2019zł4mzł563k

zł93m

Sep 30 2019n/an/a

zł145m

Jun 30 2019n/an/a

zł160m

Mar 31 2019n/an/a

zł201m

Dec 31 2018zł4mzł838k

zł227m

Compensation vs Market: Wieslaw's total compensation ($USD5.27M) is above average for companies of similar size in the Polish market ($USD585.31K).

Compensation vs Earnings: Wieslaw's compensation has been consistent with company performance over the past year.

CEO

Wieslaw Klimkowski

20.2yrs

Tenure

zł20,278,000

Compensation

Mr. Wieslaw Klimkowski serves as the President of the Management Boards at Rokita S.A. and Silesia-Kalk Sp. z o.o. Mr. Klimkowski served as Director of Investor Supervision & Group Development of PCC Rokit...

Leadership Team

NamePositionTenureCompensationOwnership
Wieslaw Klimkowski
President of the Management & General Director20.2yrszł20.28m0.50%
PLN 7.5m
Rafal Zdon
Vice President of the Management Board & Financial Director15.2yrszł16.59m0.34%
PLN 5.0m
Robert Pabich
Secretary of the Supervisory Board & Independent Member of Supervisory Board10.3yrszł207.00kno data
Beata Dobecka
Chief Accountantno datano datano data

15.2yrs

Average Tenure

Experienced Management: PCR's management team is seasoned and experienced (15.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Pabich
Secretary of the Supervisory Board & Independent Member of Supervisory Board9yrszł207.00kno data
Alfred Pelzer
Chairman of the Supervisory Board12.8yrsno datano data
Waldemar Preussner
Deputy Chairman of Supervisory Board12.8yrsno datano data
Mariusz Dopierala
Member of Supervisory Board9.2yrszł204.00kno data
Arkadiusz Szymanek
Independent Member of Supervisory Board8.2yrszł307.00kno data

9.2yrs

Average Tenure

Experienced Board: PCR's board of directors are considered experienced (9.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/12 02:40
End of Day Share Price 2025/03/12 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PCC Rokita SA is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tomasz DudaErste Group Bank AG
Jakub SzkopekErste Group Bank AG
Adam MilewiczPKO BP Securities